Zelmac Chiesa News Today : Breaking News, Live Updates & Top

Nektar Therapeutics Announces Phase 1b Data for Novel T Regulatory Cell Stimulator NKTR-358 (LY3471851) in Patients with Atopic Dermatitis

Published: December 15, 2021

/PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced that its partner Eli Lilly & Company presented preliminary results from a Lilly-sponsored...

Source: prnewswire.com

Zelmac Chiesa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Top News In Zelmac Chiesa Today - Breaking & Trending Today

Nektar Therapeutics Announces Phase 1b Data for Novel T Regulatory Cell Stimulator NKTR-358 (LY3471851) in Patients with Atopic Dermatitis

Nektar Therapeutics Announces Phase 1b Data for Novel T Regulatory Cell Stimulator NKTR-358 (LY3471851) in Patients with Atopic Dermatitis